Research Article

Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder

Table 2

Frequency distribution of TIMP-2 (-418G/C and 303G/A) polymorphism in patients with vs. without HAND and patients with HAND vs. healthy controls.

Genotypes TIMP-2 -418G/CPatients with HAND () (%)Patients without HAND () (%) valueOR (95% CI)

GG31 (62.0%)67 (67.0%)1Reference
GC15 (30.0%)20 (20.0%)0.301.55 (0.68-3.51)
CC4 (8.0%)13 (13.0%)0.550.69 (0.20-2.32)
Alleles TIMP-2 -418G/CPatients with HAND () (%)Patients without HAND () (%) valueOR (95% CI)
G77 (77.0%)154 (77.0%)1Reference
C23 (23.0%)46 (23.0%)0.990.99 (0.55-1.78)
Genotypes TIMP-2 303G/APatients with HAND () (%)Patients without HAND () (%) valueOR (95% CI)
GG31 (62.0%)71 (71.0%)1Reference
GA17 (34.0%)28 (28.0%)0.421.36 (0.64-2.89)
AA2 (4.0%)1 (1.0%)0.244.58 (0.37-56.83)
Alleles TIMP-2 303G/APatients with HAND () (%)Patients without HAND () (%) valueOR (95% CI)
G79 (79.0%)170 (85.0%)1Reference
A21 (21.0%)30 (15.0%)0.171.57 (0.83-2.30)
Genotypes TIMP-2 -418G/CPatients with HAND () (%)Healthy controls () (%) valueOR (95% CI)
GG31 (62.0%)118 (76.6%)1Reference
GC15 (30.0%)34 (22.1%)0.072.19 (0.93-5.15)
CC4 (8.0%)2 (1.3%)0.0312.55 (1.36-115.90)
Alleles TIMP-2-418G/CPatients with HAND () (%)Healthy controls () (%) valueOR (95% CI)
G77 (77.0%)270 (87.7%)1Reference
C23 (23.0%)38 (12.3%)0.0042.66 (1.36-5.23)
Genotypes TIMP-2 303G/APatients with HAND () (%)Healthy controls () (%) valueOR ( 95% CI)a
GG31 (62.0%)106 (68.8%)1Reference
GA17 (34.0%)45 (29.2%)0.141.82 (0.82-4.053)
AA2 (4.0%)3 (1.9%)0.631.70 (0.20-14.64)
Alleles TIMP-2 303G/APatients with HAND () (%)Healthy controls () (%) valueOR (95% CI)
G79 (79.0%)257 (83.4%)1Reference
A21 (21.0%)51 (16.6%)0.121.68 (0.88-3.23)

= total number of subjects, (%) = frequency of genotypes/alleles, age-adjusted OR (odds ratio) and 95% CI (confidence intervals) were derived from logistic regression models comparing the homozygous wild-type genotype/allele (GG genotype and G allele for TIMP-2 -418G/C and 303G/A were taken as reference) with other genotypes/alleles. Significant values () and related OR (95% CI) have been shown in bold.